The Impact of Artificial Intelligence on Lung Cancer Diagnosis and Personalized Treatment.
AI Revolutionizes Lung Cancer Diagnosis & Treatment: Promising Early Detection & Personalized Care Insights! π«π€
September 15, 2025
Follow us
latest articles
Discover the newest research about AI innovations in π Oncology.
New Deep Learning Tool Enhances Precision in Cancer Treatment
New deep learning tool, Flexynesis, improves cancer treatment precision by analyzing multi-omics data and medical images. π§¬π»
September 14, 2025
ACP-EPC: an interpretable deep learning framework for anticancer peptide prediction utilizing pre-trained protein language model and multi-view feature extracting strategy.
Revolutionary ACP-EPC model predicts anticancer peptides with 93.5% accuracy! π Explore its deep learning framework and features! π§¬
September 14, 2025
[Multimodal data processing through AI: envisioning the operating room of the future].
AI in surgery: Multimodal data integration shows promise but faces infrastructure and regulatory challenges. π€π
September 13, 2025
Recent advancements in artificial intelligence-powered cancer prediction from oral microbiome.
AI and Oral Microbiome: Transforming Early Detection of Oral Cancer π¦·π€
September 11, 2025
Immunotherapies for Aging and Age-Related Diseases: Advances, Pitfalls, and Prospects.
Immunotherapies for aging show promise in targeting age-related diseases. Key advancements and challenges discussed. π§¬π
September 10, 2025
Enhancing Oncology-Specific Question Answering With Large Language Models Through Fine-Tuned Embeddings With Synthetic Data.
Revolutionizing oncology data retrieval: 9% NDCG improvement using LLMs and fine-tuned embeddings! ππ‘
September 6, 2025
AI Technology Identifies Prostate Cancer Missed by Pathologists
AI technology can detect early prostate cancer missed by pathologists, identifying subtle tissue changes in biopsies. π§¬π
September 2, 2025
Beyond the Growth: A Registry-Based Analysis of Global Imbalances in Artificial Intelligence Clinical Trials.
Global AI Clinical Trials: 596 studies, 62 countries, 35.6% in China. Urgent need for equitable collaboration! ππ€π
September 1, 2025
The Evolving Landscape of Novel and Old Biomarkers in Localized High-Risk Prostate Cancer: State of the Art, Clinical Utility, and Limitations Toward Precision Oncology.
Exploring biomarkers in high-risk prostate cancer: 50-75% relapse rate post-treatment. Genomic profiling enhances precision oncology. ππ¬
August 28, 2025